No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr5:36415200-36419200 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
2 |
chr5:36415600-36422600 |
Weak transcription |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
3 |
chr5:36415600-36423000 |
Weak transcription |
Fetal Kidney |
kidney
|
4 |
chr5:36415600-36423200 |
Weak transcription |
Brain Anterior Caudate |
brain
|
5 |
chr5:36416200-36420400 |
Enhancers |
K562 |
blood
|
6 |
chr5:36416600-36420000 |
Weak transcription |
Ganglion Eminence derived primary cultured neurospheres |
brain
|
7 |
chr5:36416800-36419800 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
8 |
chr5:36416800-36419800 |
Enhancers |
NHEK |
skin
|
9 |
chr5:36416800-36423600 |
Weak transcription |
Fetal Muscle Leg |
muscle
|
10 |
chr5:36417000-36419200 |
Enhancers |
HMEC |
breast
|
11 |
chr5:36417000-36420200 |
Enhancers |
Stomach Mucosa |
stomach
|
12 |
chr5:36417200-36419600 |
Enhancers |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
13 |
chr5:36417200-36420200 |
Enhancers |
H1 BMP4 Derived Mesendoderm Cultured Cells |
ES cell derived
|
14 |
chr5:36417400-36419200 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
15 |
chr5:36417400-36420400 |
Enhancers |
Fetal Intestine Small |
intestine
|
16 |
chr5:36417600-36419800 |
Weak transcription |
Cortex derived primary cultured neurospheres |
brain
|
17 |
chr5:36417600-36419800 |
Enhancers |
Fetal Intestine Large |
intestine
|
18 |
chr5:36417800-36419200 |
Enhancers |
Placenta |
Placenta
|
19 |
chr5:36418200-36419200 |
Enhancers |
ES-UCSF4 Cell Line |
embryonic stem cell
|
20 |
chr5:36418200-36420200 |
Bivalent Enhancer |
H1 Cell Line |
embryonic stem cell
|
21 |
chr5:36418200-36420200 |
Enhancers |
Duodenum Mucosa |
Duodenum
|
22 |
chr5:36418600-36419600 |
Weak transcription |
Small Intestine |
intestine
|
23 |
chr5:36418600-36420000 |
Enhancers |
Liver |
Liver
|
24 |
chr5:36418600-36420200 |
Bivalent Enhancer |
HUES6 Cell Line |
embryonic stem cell
|
25 |
chr5:36418600-36420200 |
Bivalent Enhancer |
iPS-20b Cell Line |
embryonic stem cell
|
26 |
chr5:36418800-36420200 |
Enhancers |
Hela-S3 |
cervix
|
27 |
chr5:36418800-36422400 |
Weak transcription |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
28 |
chr5:36418800-36423000 |
Weak transcription |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
29 |
chr5:36419000-36419800 |
Enhancers |
Primary T cells fromperipheralblood |
blood
|
30 |
chr5:36419000-36419800 |
Enhancers |
Esophagus |
oesophagus
|
31 |
chr5:36419000-36422800 |
Weak transcription |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
32 |
chr5:36419000-36423000 |
Weak transcription |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|